纳米材料靶向治疗烧伤后急性肺损伤的研究进展。
Advances in nanomaterial-targeted treatment of acute lung injury after burns.
机构信息
Department of Burns, The First Affiliated Hospital of Anhui Medical University, Hefei, 230022, P. R. China.
School of Biomedical Engineering, Anhui Medical University, Hefei, 230022, P. R. China.
出版信息
J Nanobiotechnology. 2024 Jun 18;22(1):342. doi: 10.1186/s12951-024-02615-0.
Acute lung injury (ALI) is a common complication in patients with severe burns and has a complex pathogenesis and high morbidity and mortality rates. A variety of drugs have been identified in the clinic for the treatment of ALI, but they have toxic side effects caused by easy degradation in the body and distribution throughout the body. In recent years, as the understanding of the mechanism underlying ALI has improved, scholars have developed a variety of new nanomaterials that can be safely and effectively targeted for the treatment of ALI. Most of these methods involve nanomaterials such as lipids, organic polymers, peptides, extracellular vesicles or cell membranes, inorganic nanoparticles and other nanomaterials, which are targeted to reach lung tissues to perform their functions through active targeting or passive targeting, a process that involves a variety of cells or organelles. In this review, first, the mechanisms and pathophysiological features of ALI occurrence after burn injury are reviewed, potential therapeutic targets for ALI are summarized, existing nanomaterials for the targeted treatment of ALI are classified, and possible problems and challenges of nanomaterials in the targeted treatment of ALI are discussed to provide a reference for the development of nanomaterials for the targeted treatment of ALI.
急性肺损伤(ALI)是严重烧伤患者的常见并发症,其发病机制复杂,发病率和死亡率均较高。临床上已经发现了多种用于治疗 ALI 的药物,但由于容易在体内降解和全身分布,这些药物具有毒副作用。近年来,随着对 ALI 发病机制的认识不断提高,学者们开发了多种新型纳米材料,可安全有效地靶向治疗 ALI。这些方法大多涉及脂质、有机聚合物、肽、细胞外囊泡或细胞膜、无机纳米颗粒等纳米材料,通过主动靶向或被动靶向到达肺部组织,发挥作用,涉及多种细胞或细胞器。在这篇综述中,首先回顾了烧伤后 ALI 发生的机制和病理生理学特征,总结了 ALI 的潜在治疗靶点,对用于 ALI 靶向治疗的现有纳米材料进行了分类,并讨论了纳米材料在 ALI 靶向治疗中可能存在的问题和挑战,以期为 ALI 靶向治疗纳米材料的发展提供参考。
相似文献
J Nanobiotechnology. 2024-6-18
Drug Deliv Transl Res. 2024-6
Ther Adv Respir Dis. 2024
Int J Biol Macromol. 2024-1
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2017-1
Eur Rev Med Pharmacol Sci. 2016
ACS Appl Mater Interfaces. 2019-4-24
引用本文的文献
Zhejiang Da Xue Xue Bao Yi Xue Ban. 2025-7-3
Nan Fang Yi Ke Da Xue Xue Bao. 2025-4-20
本文引用的文献
Am J Physiol Lung Cell Mol Physiol. 2024-4-1
Drug Deliv Transl Res. 2024-6
ACS Nano. 2023-12-12
MedComm (2020). 2023-12-7